共 50 条
- [42] Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents A Pooled Analysis From the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (12) : 1220 - 1228
- [48] ABSORB Trial: Two Years Clinical and Angiographic Results of Clinical Evaluation of the Bioabsorbable Everolimus-Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 181I - 181I
- [50] Drug-eluting stents for the treatment of very long coronary artery stenosis: A comparison of serial angiographic follow-up with Sirolimus, Paclitaxel, Zotarolimus and Tacrolimus-eluting stent: Multicenter registry in Asia AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 145M - 145M